In malignant tumors of the hematopoietic and lymphatic system, GNA13 and RhoA mutations are present in B-cell lymphomas, mainly in DLBCL and Burkitt’s lymphoma (Justus et al., 2017). This evidence concerns the gene GNA13 and cancer.